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Abstract
Some salivary proteins degrade quickly after secretion into the oral cavity, due to
proteases present in the oral environment. DR9, the N-terminal domain of statherin is an
example of these peptides, which sustains the activity of the original protein. Inspired by
naturally occurred DR9 and the evolutionary pathway taken by proteins; we constructed
novel peptides by combining the functional domains of different salivary proteins and
investigated the functionality of these peptides. Our results revealed that DR9 duplication
could increase its functionality and DR9 combination with RR14, the functional domain of
histatin, could combine the functions of both peptides. Furthermore, we explored the
possibility of using chitosan, an amino-polysaccharide, as a carrier for salivary peptides.
Chitosan nanoparticles showed a significant higher killing effect compared to non-particle
chitosan against Candida albicans. Moreover, chitosan nanoparticles showed a favorable
killing effect in specific pHs, similar to the critical pHs in the oral cavity.

Keywords
Salivary proteins, chitosan nanoparticles, Candida albicans, Acquired enamel pellicle,
Statherin, Histatin, Oral candidiasis, Oral homeostasis, Salivary peptides

ii

Co-Authorship
All chapters were written by Tayebeh Basiri and edited by Walter L. Siqueira, DDS, PhD.
Walter L. Siqueira provided guidance throughout the whole study, including experimental
design, data interpretation, statistical analyses and technical advice for all parts of the study.
Yizhi Xiao, MSc, PhD, provided technical support for all the experimental parts and offered
generous knowledge and consult throughout the study.
All experiments were performed by Tayebeh Basiri except the followings:
Rajesh Kumar Gupta, MSc, constructed the chitosan nanoparticles for this study and
provided substantial guidance during performing chitosan related parts of the study.
Nicole Johnson, DDS, performed the enamel demineralization assay and calcium and
phosphate analyses in chapter 3.

iii

Acknowledgments
I would like to thank my lovely husband, Mehdi for his endless support and love and
for making me believe that there is no limit for success. Thanks to my parents for bringing
me to the world where I can make a change and for all their hard work, so I can be where I
am today. Words cannot express my thankfulness enough. Thanks to Kazem for the long
relieving late night chats. Thanks to my soul sisters, bafi, nas and par for all the
encouragement and love and for making the best memories of my life. Thanks to my family
for believing in me and for setting no limit at all the stages of my life. Special thanks to my
sister Marzieh and his kind husband for their unlimited support during my studies.
I also would like to express my sincere gratitude to my supervisor, Dr. Walter
Siqueira, for all his support and for letting me pursue my graduate studies in his laboratory.
Thanks to my advisors, Dr. Amin Rizkalla and Dr. Ruth Martin. Thanks to Cindy, for her
tremendous help in the lab. Thanks to all past and current Siqueira lab members for making
unforgettable memories. I will always remember the coffee breaks.
Lastly, I want to express my sense of gratitude to all people who, directly or
indirectly, have helped me throughout this journey.

iv

Table of Contents
Abstract ............................................................................................................................... ii
Co-Authorship ................................................................................................................... iii
Acknowledgments ............................................................................................................. iv	
  
Table of Contents ................................................................................................................ v	
  
List of Tables ................................................................................................................... viii	
  
List of Figures .................................................................................................................... ix	
  
List of Abbreviations .......................................................................................................... x	
  
Chapter 1 ............................................................................................................................. 1	
  
1.1	
   Introduction (Problem statement in saliva biology) ............................................... 1	
  
1.2	
   References............................................................................................................... 7	
  
Chapter 2 ........................................................................................................................... 11	
  
2	
   Protein adsorption on the enamel and their biological function .................................. 11	
  
2.1	
   Introduction........................................................................................................... 11	
  
2.2	
   AEP Composition ................................................................................................. 13	
  
2.2.1	
   Amylase .................................................................................................... 14	
  
2.2.2	
   Histatins .................................................................................................... 15	
  
2.2.3	
   Mucin ........................................................................................................ 17	
  
2.2.4	
   Proline-rich proteins (PRPs) ..................................................................... 19	
  
2.2.5	
   Statherin .................................................................................................... 21	
  
2.2.6	
   Lysozyme .................................................................................................. 22	
  
2.3	
   References............................................................................................................. 24	
  
Chapter 3 ........................................................................................................................... 36	
  
3	
   Duplication and Hybridization of Protein Functional Domains for Oral Homeostasis 36	
  
v

3.1	
   Introduction........................................................................................................... 36	
  
3.2	
   Materials and Methods ......................................................................................... 38	
  
3.2.1	
   Protein and peptides characterization ....................................................... 38	
  
3.2.2	
   Calculation of protein and peptide isoelectric points ............................... 38	
  
3.2.3	
   Enamel demineralization assay................................................................. 39	
  
3.2.4	
   Calcium and phosphate analyses .............................................................. 39	
  
3.2.5	
   Candida albicans killing assay ................................................................. 40	
  
3.2.6	
   Statistical analyses .................................................................................... 40	
  
3.3	
   Results................................................................................................................... 41	
  
3.4	
   Discussion ............................................................................................................. 46	
  
3.5	
   References............................................................................................................. 49	
  
4	
   The effect of pH on killing properties of chitosan nanoparticles against Candida
albicans ........................................................................................................................ 52	
  
4.1	
   Introduction........................................................................................................... 52	
  
4.2	
   Material and methods ........................................................................................... 54	
  
4.2.1	
   Chitosan nanoparticles’ construction ........................................................ 54	
  
4.2.2	
   Candida albicans killing assay .................................................................. 55	
  
4.2.3	
   Evaluation of cell viability........................................................................ 55	
  
4.2.4	
   Chitosan nanoparticles suspension ........................................................... 55	
  
4.3	
   Results................................................................................................................... 56	
  
4.3.1	
   Chitosan nanoparticles possess a more effective antifungal activity
compared to plain chitosan ....................................................................... 56	
  
4.3.2	
   The Killing effect of chitosan nanoparticles made with different initial
concentrations of chitosan proved to be significantly different................ 58	
  
4.3.3	
   Chitosan nanoparticles show a most efficient killing effect in pH 4 ........ 60	
  
4.4	
   Discussion ............................................................................................................. 63	
  
4.5	
   References............................................................................................................. 65	
  
vi

5	
   Conclusion and discussion ........................................................................................... 67	
  
5.1	
   General rationale and conclusion.......................................................................... 67	
  
5.2	
   Final Conclusion ................................................................................................... 72	
  
5.3	
   Challenges and limitations .................................................................................... 73	
  
5.4	
   Future directions ................................................................................................... 73	
  
5.5	
   References............................................................................................................. 75	
  
Curriculum Vitae .............................................................................................................. 79	
  

vii

List of Tables
Table 3-1: Constructed peptides derived from statherin and histatin and their calculated pI.
Note. pS is a phosphorylated serine. ....................................................................................... 41	
  
Table 3-2: Calcium and phosphate release from human enamel sections .............................. 43	
  
Table 4-1: IC50 of different groups against Candida albicans. .............................................. 62	
  

viii

List of Figures
Figure 3-1: Candida albicans killing Assay of newly constructed peptides and histatin3...... 45	
  
Figure 4-1: Killing effect of chitosan nanoparticles and non-nanoparticle chitosan against
Candida albicans. .................................................................................................................... 57	
  
Figure 4-2: Killing effect of chitosan nanoparticles made with different initial chitosan
concentrations. ........................................................................................................................ 59	
  
Figure 4-3: Killing effect of chitosan nanoparticles in different pHs. .................................... 61	
  

ix

List of Abbreviations
AEP

Acquired enamel pellicle

PRPS

Proline-rich proteins

GlcN

D-glucosamine

GlcNAc

N-Acetyl glucosamine

MWs

Molecular weights

bPRP

Basic or glycosylated PRP

aPRP

Acidic PRP

HA

Hydroxyapatite

SVs

Statherin variants

MG1, 2

Mucin glycoprotein 1, 2

TEM

Transmission electron microscopy

IgA

Immunoglobulin A

SDA

Sabouraud dextrose agar

TPP

Tripolyphosphate

MRSA

Multidrug-resistant S. aureus

ROS

Reactive oxygen species

HPLC

High performance liquid chromatography

PI

Isoelectric point

OD

Optical density

LC-ESI-MS/MS

Liquid chromatography-electrospray ionization-tandem mass spectrometry

MALDI-TOF-MS Matrix assisted laser desorption/ionization-time of flight-mass spectrometry

x

1

Chapter 1
1.1

Introduction (Problem statement in saliva biology)

Saliva is composed of hundreds of salivary proteins secreted from a few major
salivary glands and many minor salivary glands, including submandibular, sublingual and
parotid glands and several non-salivary components (Dawes, C et al. 2004). Some
salivary proteins are secreted commonly from all major glands, such as the secretory IgA
(the main antibody in saliva), but some proteins are exclusive to specific gland such as
proline-rich proteins (PRPs), which appear to be secreted only from parotid glands and
minor salivary glands (Dawes, C et al. 1963 and Siqueira, W et al. 2008). Saliva is one of
the most important fluids in the body that performs critical roles in the oral environment,
such as facilitating the taste and detection of foods nutritious to the body and acting as a
lubricant and antimicrobial agent. Saliva also prevents the dissolution of teeth and aids
digestion. In addition, saliva is responsible for forming the acquired enamel pellicle
(AEP), a thin organic layer formed on the enamel surface of the teeth (Dawes, C et al.
1963).
Extensive studies have been done to elucidate the process by which the AEP is
formed on the enamel surface of the tooth. Briefly, one minute after exposure to the oral
environment, a thin pellicle layer is detected on the enamel (Hannig, M et al. 1999). This
pellicle formation is completed after 120 minutes and no further increase in
protein/peptide is observed. However, a significant number of bacteria start adhering and
forming the so-called oral biofilm or dental plaque (Siqueira W et al. 2012). Extensive
electron microscopy experiments have been employed to determine the structure of the
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acquired enamel pellicle and the majority of these experiments have shown that the
thickness of pellicle is within the range of 30 and 100 nm (Hannig, M et al. 1989;
Tinanoff, N et al. 1976).
Over the years, several groups have utilized different experimental models to
investigate the composition of AEP. For example, in vitro models such as hydroxyapatite
(HA) discs incubated with whole saliva and HA powder were used to study the AEP. The
use of these models resulted in the identification of some major AEP proteins such as
amylase, histatins, albumin, carbonic anhydrase VI, cystatins, statherin, lysozyme and
proline-rich proteins (PRPs) (Jensen, JL et al. 1992; Li, J et al. 2004; Hannig, M et al.
1999). More recently, application of sensitive techniques such as LC-ESI-MS/MS and
MALDI-TOF-MS has led to the identification of 130 proteins in the AEP composition
(Siqueira, W et al. 2007). Of these 130 identified proteins, 113 were novel proteins.
Statherin, PRPs, cystatins and histatins are the major components of the AEP and make a
substantial portion of proteins present in saliva (Hay, D et al. 1975; Oppenheim, FG et al.
1986; Hay, D et al. 1973; Oppenheim, FG et al. 1971). Additionally, these techniques
identified 78 naturally occurring AEP peptide derived from 29 different proteins within
the in vivo pellicle (Siqueira, W and Oppenheim, FG et al. 2009). Multiple peptides
identified in AEP peptidome originate from histatins and statherin.
The AEP plays an important role as a lubricant in the oral environment, which in
turn improves the efficiency of speech and chewing (Tabak, LA et al. 1982). Mucins,
aPRP1 and statherin are AEP constituents that are involved in this process (Tabak, LA et
al. 1995; Vukosavljevic, D et al. 2014; Hahn Berg, IC et al. 2004). Due to its lubrication
properties, AEP also plays a protective role against abrasive damage (Joiner, A et al.
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2008). Furthermore, several studies have shown that multiple AEP components provide
protection against acid-induced enamel demineralization (Hannig, M and Balz, M et al.
2001; Cheaib, Z and Lussi, A et al. 2011; Siqueira, W et al. 2010).
Statherin is a salivary protein that is phosphorylated at serine residues at position
2 and 3. Statherin has highly important physical properties crucial for saliva. This protein
is the most surface-active saliva component (Proctor, GB et al. 2005) and functions as an
important lubricant in the saliva (Douglas, WH et al. 1991, Harvey, NM et al. 2011).
Statherin and aPRPs play a role in inhibiting crystal deposition on enamel surfaces (Hay,
DI and Moreno, EC et al. 1979). However, statherin is the most crucial inhibitor of
calcium phosphate precipitation, which can serve its inhibitory effect at physiological
concentrations (Tamaki, N et al. 2002). Furthermore, recent findings from our laboratory
revealed that phosphate groups in the N-terminal domain of statherin fragments are
responsible for inhibiting the growth of hydroxyapatite crystal. Moreover, statherin
quickly disappear from whole saliva due to proteolytic activity and its affinity for tooth
surfaces.
Histatins are a protein family present in the AEP, which are secreted by the major
and minor salivary glands. Histatins contain high level of histidine (Oppenheim, FG et al.
1986) and show antifungal activity against Candida albicans, the major cause of oral
candidiasis. Of the 12 members of histatin family, Histatin 1, 3 and 5 are the major
members of the histatin family, forming 80% of this family (Oppenheim, FG et al. 1988).
Like statherin, histatin 1 is phosphorylated at serine 2. Histatins show lower
concentrations in whole saliva compared to pure glandular secretions likely due to
proteolytic activity of saliva resulting the rapid degradation of these proteins after their
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release into the oral cavity. Furthermore, histatins play a role in multiple processes,
including buffering, modulation of mineral formation and antibacterial activities
(Castagnola, M et al. 2004; Groot, F et al. 2006).
Chitosan, an amino-polysaccharide, is a derivative of chitin, which is mainly
present in the exoskeletons of arthropods such as insects, in algae and in some fungal cell
walls. Chitosan is made from chitin by alkaline deacetylation, achieved by boiling chitin
in concentrated alkali such as NaOH for 7-10 hours (Rabea, EI et al. 2003; Kumar, MNV
et al. 2000). In terms of chemistry, chitosan is a polycationic heteropolysaccharide, which
consists of two monosaccharides, D-glucosamine (GlcN) and N-Acetyl glucosamine
(GlcNAc), linked by β (1→4) glycosidic bonds (Pochanavanich, P and Suntornsuk, W et
al. 2002; Singla, AK and Chawla, M et al. 2001). Several features of chitosan such as
molecular weights (MWs) viscosities, pKa values may be affected by the relative amount
of these two monosaccharides in the composition of chitosan (Singla, AK and Chawla, M
et al. 2001; Tharanathan, RN and Kittur, FS et al. 2003).
Chitosan has a higher killing rate and lower toxicity rate compared to other types
of disinfectants that make chitosan a better antimicrobial agent (Franklin, TJ et al. 1981;
Takemono, K et al. 1989). Multiple mechanisms have been proposed to explain how
chitosan serves its antimicrobial activity; however, the exact mechanism remains to be
discovered. Chitosan can change cell permeability by interacting with the membrane of
the bacterial cell, which leads to the leakage of cellular compartments and the death of
bacteria (Seo, HJ et al. 1992; Chen, CS et al. 1998). Chitosan also can inhibit microbial
growth and the production of toxins by acting as a chelator that selectively binds to trace
metals (Cuero, RG et al. 1991). Other proposed mechanisms for antimicrobial activity of
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chitosan include the inhibition of mRNA synthesis and various enzyme activities
essential for bacterial survival (Sudarshan, NR et al 1992). It is interesting to mention that
chitosan demonstrates its strong antibacterial activity only in an acidic condition because
its solubility drastically decreases in pHs above 6.5. Furthermore, different molecular
weights of chitosan can have the opposite effect on antimicrobial activity. For instance,
chitosan with a molecular weight ranging from 10,000 Da to 100,000 Da inhibited the
growth of bacteria, whereas, chitosan with an average molecular weight of 2,200 Da
enhanced the growth of bacteria (Tokura, S et al. 1994). Nano and microparticles have
recently gained substantial attention as carriers for drugs and proteins. These particles can
control the release of drugs and proteins to a specific target site, which minimize
nonspecific effects. Chitosan displays some biological features such as biodegradability,
biocompatibility and pH sensitivity that make chitosan a suitable carrier for the delivery
of drugs and proteins in the biomedical field. Encapsulation of salivary proteins/peptides
in chitosan particles provides an opportunity for these proteins/peptides to have a longer
lifespan in the oral environments.
The aim of this study was to investigate the novel constructed histatin and
statherin peptides’ activity, compared to the original proteins and also, to explore the
possibility of using chitosan nanoparticles as a delivery system for salivary
peptides/proteins. We hypothesized that only the functional domain of selected salivary
proteins could have the same function as the original proteins, also, the
duplication/combination of protein functional domains could increase/combine their
activity. This novel approach of salivary peptides’ construction could help us to benefit
from the result of evolution millions of years ahead of the time that it would naturally
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occur, since these could be the evolutionary pathways that salivary proteins will
eventually take. Moreover, the idea of chitosan nanoparticles application for
peptides/proteins delivery could be highly beneficial since, not only it will increase the
peptides’ life span in the oral cavity but it can also provide bonus antimicrobial and
antifungal properties.
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Chapter 2

2

Protein adsorption on the enamel and their biological
function

2.1 Introduction
The AEP is an organic layer, free of bacteria, that coats the tooth surfaces. AEP
consists of proteins, glycoproteins and enzymes (Lendenmann, K et al. 2000), and plays
important roles in several processes in the oral cavity. For instance, it is responsible for
lubricating tooth surfaces to prevent wear. It also acts as a buffer and anti-erosive barrier.
Furthermore, it displays multiple antimicrobial properties (Hannig, M et al. 2001; AlHashimi, I et al. 1989; Bradway, SD et al. 1992; Hannig, M et al. 2002; Hannig, M and
Balz, B et al. 1999; Amaechi, BT et al. 1999; Hannig, M et al. 1999 and Hahn Berg, IC et
al. 2004).
AEP postpones enamel demineralization (Darling, AI et al. 1956; Meckel, AH et
al. 1968; Zahradnik, RT et al. 1976; Propas, D et al. 1977; Juriaanse, AC et al. 1979) and
impedes the supersaturated saliva to form calcium and phosphate crystal on the tooth
surface (Hay, DI et al. 1979; Moreno, EC et al. 1979). It is a key player in the
colonization of bacteria on the tooth surface by mediating the selective binding of
bacteria (Hillman, JD et al. 1970; McGaughey, C et al. 1971; Gibbons, RJ et al. 1976).
It has been shown that there is no increase in the amount of amino acid formed on
the tooth surface after 90 minutes (Sonju, T et al. 1973). X-ray studies have revealed that
there is equilibrium between adsorption and re-sorption of proteins on the tooth surface
after 90 min (Kuboki, Y et al. 1987).
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The majority of research in the salivary protein field has focused on the chemical
composition of the AEP with little focus on its ultrastructure. The initial transmission
electron microscopic (TEM) studies characterized the AEP as a bacteria-free,
homogeneous and amorphous layer (Armstrong, WG et al. 1968; Leach, SA et al. 1966;
Meckel, AH et al. 1965 and Tinanoff, N et al. 1976). Further investigations of the AEP at
different time points revealed a more complicated structure as the 2-hour AEP
demonstrated a fine, uneven organic layer and after the maturation of the AEP during a
period of several hours, it forms a compact layer with the granular structure (Berthold, P
et al. 1979; Lie, T 1977; Nyvad, B et al. 1987 and Tinanoff, N et al. 1976).
Although these investigations provided helpful insights into the AEP structure,
there have been some limitations. For example, they were performed on enamel slabs
carried in the buccal sulcus. Since the oral cavity is exposed to different salivary gland
secretions with different protein composition, a systematic ultrastructural study
investigating site-dependent differences in the structure of the AEP was needed (Dawes,
C et al. 1993; Dawes, C et al. 1989; Sas, R et al. 1997; Brookes, SJ et al. 1995 and
Veerman, ECI et al. 1996). In 1999, Hannig performed an experiment using TEM to
investigate the structure of the AEP at two different oral sites for a period of 24 hours.
This experiment demonstrated that a thin layer with thickness of 10–20 nm is formed on
the enamel surface after one minute. Further adsorption of salivary proteins was
controlled by locally effective shearing forces of the oral cavity. The lingual site of the
oral cavity was covered by homogeneous, granular layer with a thickness of 20 to 80 nm
in 2 hours, which increased to the thickness of 100–200 nm after 24 hours. In contrast, on
the buccal surface, a granular and globular layer with the thickness of 200 and 700 nm
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was formed after 2 hours, which increases to a globular layer with the thickness of 10001300 nm. Other researchers also confirmed the globular and granular structures of the
AEP (Schupbach, P et al. 1996).
In summary, these findings revealed that the AEP formation occurs in two steps:
First, salivary proteins are adsorbed on the enamel surface as an electron dense basal
layer, subsequently; salivary proteins are adsorbed on the enamel surface forming a
globular layer. These investigations also showed that the structural appearance and
formation of pellicle changes by site dependent salivary composition, different salivary
flow rate and effective shearing forces.
The identification of the AEP protein composition has been the focus of several
studies over the years. Three experimental models including in vitro, in situ and in vivo
models have been employed to investigate the AEP components. Although the in vitro
model has some limitation, in terms of mimicking the dynamic environment of the
mouth, but it provided some valuable information about the composition of the AEP
(Jensen, JL et al. 1992). This model revealed the identity of some of the major
components of the AEP such as amylase, carbonic anhydrase VI, histatins, cystatins,
lysozyme, albumin, statherin and PRPs. (Hannig, M et al. 1999; Li, J et al. 2004).

2.2

AEP Composition

The in situ model, which, uses bovine or human enamel slabs mounded in intra-oral
appliances provided valuable information about the activity and structure of the enzymes
within the AEP such as amylase, peroxidase, transaminases and lysozyme (Hannig, M et
al. 2004 and Hara, AT et al. 2006). With the emergence of sensitive proteomics

14

technology, the in vivo AEP composition could be analyzed in a small amount of sample
(Siqueira, WL et al. 2007a). These delicate techniques have provided the opportunity to
expand our information about the AEP composition. LC-ESI-MS/MS and MALDI-TOFMS are the examples of these techniques, which have made the possibility to identify 130
proteins in the in vivo AEP (Siqueira, WL et al. 2007b). Furthermore, LC-ESI-MS/MS
techniques have led to the discovery of 78 peptides that are the result of the cleavage of
29 different proteins present in the AEP (Siqueira, WL et al. 2009). These proteomics
techniques have allowed us to design complex experiments, which will lead to a greater
understanding of the AEP composition. The better understanding of the AEP components
and their activity will provide the opportunity for the development of better therapies for
oral diseases.

2.2.1

Amylase
The parotid salivary gland is the main source of salivary alpha-amylase, which is

the prevailing protein in human saliva. Amylase is produced by both salivary glands and
pancreas, providing different levels of starch digestion (Merritt, AD et al. 1973 and
Tomita, N et al. 1989). Amylase is encoded by two genes named AMY1 and AMY2.
Salivary amylase contains 496 amino acids and shows a highly similar sequence
compared to the pancreatic amylase with only 3% variation in their sequence.
Salivary amylases are divided into two families: family A and family B (Keller,
PJ et al. 1971). Family A enzymes are glycosylated at Asn 412 residue and consists of
three isomers: isoenzyme 1, 3 and 5 which are slightly different in their structure. Family
B enzymes, are non-glycosylated, and include isoenzymes 2, 4 and 6 (Takeuchi, T et al.
1979). In terms of function, alpha-amylase is involved in hydrolyzing alpha-1, 4
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glycosidic bonds, leading to the first level of starch and glycogen digestion, in the oral
cavity. Furthermore, salivary amylases are able to attach to several oral streptococci
species, indicating their role in the clearance of bacteria (Scannapieco, FA et al. 1989;
Scannapieco, FA et al. 1990; Douglas, CW et al. 1990; Bergmann, JE et al. 1995 and
Scannapieco, FA et al. 1993). Amylase is detectable in the AEP, but the exact role of this
protein on the tooth surface remains to be investigated (Al-Hashimi, I et al. 1989; Yao, Y
et al. 2003; Orstavik, D et al. 1973; Orstavik, D et al. 1974 and Dipaola, C et al. 1984).

2.2.2

Histatins
Histatins are a family of salivary proteins that consists of 12 highly similar

members. Two distinct genes mapped to chromosome 4q13, HIS1 and HIS2, encode
histatin 1 and histatin 3 respectively (Azen, EA et al. 1973 and Sabatini, LM et al. 1989).
Other members of histatin family are derived from histatin 1 and 3 by proteolytic
cleavage of salivary proteases during secretion. For instance, histatin 3 undergoes a
proteolytic cleavage at Tyr-24 within salivary gland cells and creates histatin 5 (Sabatini,
LM et al. 1989). In addition, histatin 1 undergoes other post-translational modifications.
One such example is the phosphorylation of histatin 1 at serine 2 and sulfation of tyrosine
residues at the C-terminal of histatin 1 (Oppenheim, FG et al. 1988 and Cabras, T et al.
2007). These salivary cationic peptides defend the oral environment against oral
candidiasis caused by Candida albicans. Among all histatins, histatin 5 and 3 have the
highest antifungal activity (Xu, T et al. 1991).
Earlier studies revealed that these histidine rich proteins are secreted from parotid
and submandibular/sublingual salivary glands. However, recent immunochemistry and
mass spectrometry techniques have shown that minor salivary glands also secrete
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histatins. Of the 12 members of this family, histatin 1, 3 and 5 constitute about 80% of
glandular secretions and contain 38, 32 and 24 amino acid residues, respectively. The
concentration of histatins in the saliva ranges from 50 µM to 425 µM (Helmerhorst, EJ et
al. 1997).
Previous studies have revealed that the N-terminal domain of these histatins is
responsible for antimicrobial activity and the C-terminal domain possesses woundhealing properties (Melino, S et al. 1999; Gusman, H et al. 2001 and Grogan, J et al.
2001).
The oral cavity takes advantage of several defense mechanisms to prevent
bacterial and fungal infections. Histatins are the key players in protecting the oral cavity
against oral pathogens. Several studies have investigated the antibacterial activity of
histatins against different pathogens. Some studies have shown that histatins have low or
no effect on Streptococcus mutans and S. milleri (Helmerhorst, EJ et al. 1997 and Bartie,
KL et al. 2008). However, it has been demonstrated that both S. aureus and multidrugresistant S. aureus (MRSA) are sensitive to the antimicrobial activity of histatin 5 and its
homolog peptides such as Dh5, P-113, Dhvar5 and in particular Dhvar4 which shows an
IC50 of 3.1–4.2 µM in vitro and 1–1.5 µM in vivo, respectively (Welling, MM et al.
2007). In addition, histatin 1 inhibits the adsorption of glycoprotein to hydroxyapatite
surfaces, which results in reduction of S. mutans adhesion to hydroxyapatite surfaces
(Shimotoyodome, A et al. 2006). Histatin 5 is responsible for regulating the
periodontopathic bacterium Porphyromonas gingivalis, and hindering the induction of
inflammatory cytokines in human gingivalis fibroblasts by P. gingivalis (Imatani, T et al.
2000; Imatani, T et al. 2004 and Yoshinari, M et al. 2010). Furthermore, histatins show a
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strong antifungal effect against C. albicans, C. krusei, Cryptococcus neoformans,
Saccharomyces cerevisiae and Neurospora crassa in vitro (Oppenheim, FG et al. 1988;
Rayhan, R et al. 1992; Driscoll, J et al. 1996; Tsai, H et al. 1997 and Vukosavljevic, D et
al. 2012). Histatin 5 serves its candidacidal activity through a multistep molecular
mechanism. First, histatin 5 binds to the yeast protein receptor Ssa1/2p that activates the
internalization of the peptide. Finally, histatin 5 interacts with intracellular targets such as
mitochondrial membrane leading to the formation of reactive oxygen species (ROS) and
oxidative damage (Edgerton, M et al. 1998; Sun, JN et al. 2008; Baev, D et al. 2001; Xu,
Y et al. 1999; Helmerhorst, EJ et al. 1999; Koshlukova, SE et al. 2000; Ruissen, AL et al.
2001 and Isola, R et al. 2007). In addition, it has been demonstrated that histatin 5
induces ATP efflux from C. albicans cells by interacting with TRK1p, a potassium
transporter, and inducing potassium ion release (Baev, D et al. 2004). The exact and
detailed mechanism for antifungal activity of histatins remains to be elucidated. A better
understating of these mechanisms might provide better opportunities for the development
of new generation antifungal drugs. Histatins are one of the earliest precursors of the
AEP due to their high affinity to the hydroxyapatite and they aid the AEP protection of
teeth from demineralization (Jensen, JL et al. 1992; Al-Hashimi, I et al. 1989; Siqueira,
W et al. 2010). Histatins also contribute to the antimicrobial property of AEP by
inhibiting bacteria adhesion to the tooth's surface and providing antimicrobial and
antifungal properties in the AEP composition (Xie, H et al. 1991 and Siqueira, W et al.
2007b).

2.2.3

Mucin
Mucins are other members of saliva, which are divided into two types of
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genetically different salivary mucins: mucin glycoprotein 1 (MG1), also called high
molecular weight mucin, encoded by the MUC5B gene (Thornton, DJ et al. 1999), and
the MG2 (Mucin glycoprotein 2), or low molecular weight mucin, encoded by the MUC7
gene (Bobek, LA et al. 1993). 11 distinct Mucin genes have been mapped in human so
far; each of these different mucins shares several sequences and features.
MG1 is secreted from mucous cells, while MG2 is secreted from serous cells.
Mucins contain a high level of carbohydrate chains attached covalently to their
polypeptide backbones and are rich in proline and serine/threonine. These carbohydrate
chains make up to 60% to 80% of the molecule (Van Klinken, BJ et al. 1995). MG1 is a
component of the AEP that is responsible for lubricating the dental surfaces and
protecting it against mechanical wear (Nieuw Amerongen, AV et al. 1987). Mucins also
participate in the acid resistance of the AEP (Cheaib, Z and Lussi, A et al. 2011). In
addition, mucins function as a barrier against penetration of irritants and toxins into
mucous cells. They regulate permeability of mucosal surfaces, and play a protective role
against proteases generated by bacteria and modulate colonization of the oral cavity by
bacteria and viruses (Mandel, ID et al. 1987). 30% of the salivary mucins are secreted
from the submandibular glands, while 70% of them are secreted from sublingual, labial
and palatal glands. Interestingly, parotid glands do not secrete any mucins (Wu, AM et al.
1994; Thornton, DJ et al. 1999; Nielsen, PA et al. 1996; Troxler, RF et al. 1997; Milne,
RW et al. 1973 and Edgerton, M et al. 1992). Furthermore, mucins facilitate speech,
chewing and swallowing by the viscoelastic properties. In addition, MGl has the ability to
bind to a variety of microorganisms such as

Porphyromonas gingivalis and Candida
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albicans and contribute in their clearance from the oral cavity (Amano, A et al. 1994;
Edgerton, M et al. 1993).

2.2.4

Proline-rich proteins (PRPs)
PRPs are divided into two subcategories: Basic or glycosylated PRPs (bPRPs) and

acidic PRPs (aPRPs). bPRPs are encoded by four loci (PRB1-PRB4), mapped to
chromosome 12p13 and only secreted by parotid glands. aPRPs are the product of two
loci (PRH1 and PRH2), mapped to chromosome 12p13 close to the bPRPs loci, and are
detected in both parotid and submandibular/sublingual secretions (Kauffman, DL et al.
1991 and Inzitari, R. et al. 2005). All PRPs have a repeat region, a signal peptide, a
carboxyl terminal region and a transition region in common (Ann, DK et al. 1985)
All aPRPs undergo post-translational modification such as phosphorylation of
residues 8 and 22. Acidic PRPs effectively inhibit the calcium phosphate crystal growth,
but they do not play a role in crystal nucleation, which occurs by calcium phosphate
precipitation at physiological concentrations. The N-terminal domain of aPRPs, which
contains 30 amino acids, including two phosphoserine and several negatively charged
residues, is responsible for inhibiting the calcium phosphate crystal growth. Studies have
shown that the presence of both phosphoserines at the N-terminal domain of aPRPs plays
a crucial role in mineral homeostasis. This domain also has a high affinity for binding to
the hydroxyapatite (HA). The intact PRPs are absent in saliva indicating their complete
cleavage in the oral cavity. More than 20 PRPs have been identified in human saliva
(Bennick, A 2002). Several studies have shown that different peptides are derived from
the cleavage of basic PRPs including Pe (DEAEII-2), PmS, Con1, Ps, Pc, Con2, PmF,
and Po (Kauffman, DL et al. 1979; Azen, EA et al., 1979 and 1980; Anderson, LC et al.
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1982; Azen, EA et al. 1984a; Karn, RC et al. 1985). In addition, basic PRPs are cleaved
to multiple fragments which include P-D, P-F, P-E, P-I and P-H, II-1, II-2, IB-7, IB-8a
and IB-1 fragments (Isemura, S et al. 1982; Saitoh, E et al.1983a, b, c; Kauffman, D et al.
1982, 1986, 1991). The structure of basic PRPs is well known and characterized but their
exact function in the oral cavity is yet to be discovered.
PRPs were identified in human saliva for the first time (Mandel, ID et al. 1965).
Further studies showed that these proteins are present in the saliva of several animals as
well, such as rat, goat, sheep and mouse. In terms of molecular weight, PRPs range from
5000 to over 25000 Daltons (McArthur, C et al. 1995 and Bennick, A et al. 2002). PRPs
produced in some species such as human contained about 40% Proline indicating their
unique structure considering the fact that most proteins only contain about 5% proline in
their structure (Mole, S et al. 1990; Mehansho, H et al. 1983 and 1985; Schulz, GE and
Schirmer, RH et al. 1979).
Parotid saliva possesses the highest concentration of PRPs among all salivary
glands (Veerman, EC et al. 1996). Acidic PRPs contain a longer N-terminal region, and
their repeated sequence is different compared to basic PRPs (Bennick, A et al. 2002).
Acidic PRPs are able to bind to calcium hydroxide and therefore are involved in the
formation of AEP on tooth surfaces. PRPs contribute to the lubricating property of AEP
and inhibit the calcium and phosphate precipitation on the enamel surface along with
some other proteins (Vitorino, R et al. 2008; Tabak, LA et al. 1995; Hahn Berg, IC et al.
2004; Hay, DI and Moreno, EC et al. 1979). Basic PRPs have been also detected in the
AEP (Vitorino, R et al. 2008). Acidic PRPs are able to bind to bacteria, whereas basic
and glycosylated PRPs have the ability to bind to fungi, viruses and bacteria, which is an
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indicative of their role in the exclusion of these microorganisms (Fábián, TK et al. 2008;
Fábián, TK et al. 2012; Shugars, DC et al. 1998 and Tenovuo, J et al. 2002).

2.2.5

Statherin
Statherin inhibits the nucleation as well as the growth of hydroxyapatite in the

supersaturated environment of saliva; therefore, as an AEP component, it avoids the
crystal formation on the tooth surface (Schlesinger, DH et al. 1977; Hay, DI Moreno, EC
et al. 1979). Statherin also functions as a boundary lubricant and a mediator of bacterial
adhesion in periodonto-pathology (Douglas, WH et al. 1991).
The major statherin contains 43 residues and is detectable in human parotid and
submandibular salivary glands (Hay, DI et al. 1977). Statherin inhibits the spontaneous
precipitation of calcium phosphate salts from their supersaturated solutions (Hay, DI and
Moreno, EC et al. 1979). Therefore, statherin, in conjunction with acidic PRPs, is able to
inhibit precipitation of calcium phosphate salts in the salivary glands, the mouth and onto
the tooth surface ((Hay, DI et al. 1979).
Like other calcium-binding proteins such as Osteopontin and biomineralization
proteins regulating calcium carbonate crystallization, statherin contains a pSpSEE (where
pS is phosphorylated serine) acidic motif (Waite, JH et al. 2001). Statherin is
phosphorylated at two serine residues in position 2 and 3 and has a high level of tyrosine
and proline (Schlesinger, DH et al. 1977). Initially, it was believed that statherin exists as
a single protein in human saliva until smaller statherin variants (SVs) were identified
(Jensen, JL et al. 1991). There are three SVs, including SV1, 2 and 3. SV2 lacks an
internal 10-residue segment, which is the result of eliminating exon 4 of statherin gene by
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an alternate mRNA splicing event. SV1 and SV3 are similar to statherin except that they
are missing a phenylalanine residue at the C terminal domain. The removal of this residue
is thought to be a post-translational modification (Jensen JL et al. 1991 and Castagnola,
M et al. 2003). Interestingly, similar to histatins, the concentration of statherin in
glandular secretions is significantly higher than in whole saliva due to its proteolytic
degradation and strong affinity for tooth surfaces. Statherin, an AEP component, inhibits
primary as well as secondary calcium phosphate precipitation, and therefore is thought to
have a crucial role in maintaining oral fluid, supersaturated with calcium phosphate salts,
which is an important function for the remineralization capacity of human saliva
(Schlesinger, DH et al. 1977; Hay, DI et al. 1982 and Moreno, EC et al. 1979). Statherin
also assists in the protection of tooth mineral tissue to the acid products, along with other
members of AEP (Li, J et al. 2004).

2.2.6

Lysozyme
Lysozyme is an enzyme present in the secretions of human and many other

vertebrates and invertebrates such as, phages, plants and bacteria. Because of its
abundance in human secretions, it is considered a part the innate immune system
(Goodman, H et al. 1981).
Lysozyme, also called muramidase, is a 14-kDa enzyme with antimicrobial
activity in human saliva and AEP (Siqueira, W et al. 2007b). Lysozyme serves its
antimicrobial activity through multiple mechanisms. First, it hydrolyzes the cell wall
peptidoglycans leading to the death of bacteria (Torsteinsdottir, I et al. 1999). However,
most of bacterial species are not directly lysed upon exposure to lysozyme, and further
addition of detergents is required to lyse the bacteria (Goodman, H et al. 1981; Cho, MI
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et al. 1982 and Pollock, II et al. 1987).
Lysozyme is also able to change intermediate glucose metabolism in sensitive
bacteria and, in some cases, to lead to bacterial aggregation, which can contribute to the
clearance of bacteria from the oral cavity (Pollock II et al. 1976 and Twetman S et al.
1986). Moreover, it can activate bacterial autolysins (Laible, NJ et al. 1985). In addition
to antimicrobial activity, lysozyme may play a role in protection from acute bronchitis
and oral candidiasis (Taylor, DC et al. 1995; Yeh, CK et al. 1997; Wu, T et al. 1999).
Interestingly, it has been demonstrated that non-enzymatic properties of lysozyme are
responsible for antimicrobial activity, since heat-denatured lysozyme maintains
antibacterial activity. Further studies have revealed that a small cationic amphipathic
sequence (12-15 amino acids) in the C-terminal domain of lysozyme displays
antimicrobial activity (During, K et al. 1999).
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Chapter 3

3

Duplication and Hybridization of Protein Functional
Domains for Oral Homeostasis

3.1 Introduction
Many studies have been devoted to uncovering the nature of the acquired enamel
pellicle (AEP), an organic film on the enamel surfaces, formed by the selective
adsorption of around 130 proteins, peptides, and other molecules (Hannig, M and Joiner,
A et al. 2006; Siqueira, W et al. 2007; Vitorino, R et al. 2007). These proteins, primarily
originate from salivary glands, bacterial products, gingival crevicular fluid, or oral
mucosa (Siqueira, W et al. 2012). However, salivary peptides are merely products of
these proteins after bacterial cleavage and may retain or augment the functional
properties of their native proteins (Castagnola, M et al. 2004; McDonald, EE et al. 2011;
Siqueira, W and Oppenheim, FG et al. 2009). The AEP plays a crucial role in dental
homeostasis by neutralizing acids from bacterial products and acting as a selectively
permeable membrane for de-remineralization (Hara, AT and Zero, DT et al. 2010;
Siqueira, W et al. 2010; Siqueira, W et al. 2012; Zahradnik, RT and Moreno, EC et al.
1977). It also dictates the composition of early colonizers that ultimately form the
microbial biofilm (Chaudhuri, B et al. 2007; Gibbons, RJ and Hay, DI et al. 1989; Li, J et
al. 2004).
One of the AEP principal proteins is statherin, which is wholly effective at
inhibiting primary and secondary calcium phosphate precipitation (Oppenheim, FG et al.
2007; Schlesinger, DH and Hay, DI 1977) allowing for supersaturated saliva that aids in
remineralizing enamel surfaces. Statherin’s functional peptide resides at the N-terminal
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(Long, JR et al. 1998; Raj, PA et al. 1992). Recently, our group identified as a member of
the AEP a naturally occurring peptide from this region (Siqueira, W and Oppenheim, FG
et al. 2009). This peptide consists of 9 amino acids, DpSpSEEKFLR (where pS is a
phosphorylated serine). This peptide chain, termed DR9, has shown a significant effect
(p<0.05) on the hydroxyapatite growth inhibition in all studied concentrations when
compared to other native statherin peptides (Xiao, Y et al. 2010).
Frequently, salivary proteins that have existed for millions of years contain one or
more repeats of functional domains within their primary structure, thereby improving
their functional capacity under evolutionary pressures (Oppenheim, FG et al. 2012;
Troxler, RF et al. 1997). Protein diversity may be achieved through allelic variation,
gene duplication, splicing events, and post-translational modifications (Helmerhorst, EJ
and Oppenheim, FG et al. 2007; Oppenheim, FG et al. 2007). However, statherin is an
evolutionarily young protein, and as such, DR9 is the known natural functional domain in
relation to the inhibition of primary and secondary calcium phosphate precipitation (Xiao,
Y et al. 2010). Artificially duplicating or triplicating this peptide sequence may induce
the effects that we would expect to see over the course of evolution, creating a salivary
protein with enhanced dental homeostasis, such as enamel demineralization protection.
In addition to multiplying a functional domain, evolutionary processes may also
merge functional domains from different proteins for a combinatory effect. Therefore,
another AEP protein to be studied is histatin; its benefits include antimicrobial effects,
demineralization protection, buffering, and regulation of mineral formation ( Edgerton, M
and Koshlukova, SE et al. 2000; Helmerhorst, EJ et al. 2006; Siqueira, W et al. 2010;
Vukosavljevic, D et al. 2012). Histatins degrade quickly upon secretion by the salivary
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glands due to high proteolytic activity in the oral cavity, but the resulting fragments often
retain their original function (Castagnola, M et al. 2004; Groot, F et al. 2006). Our group
has characterized the peptide RR14, a synthetic analog of histatin’s antimicrobial
functional domain RKFHEKHHSHRGYR, to connect with statherin’s DR9. It has been
previously shown that the functional domain of histatins could have the same
antimicrobial effect as of the original protein. By synthetically combining RR14 with
DR9, we hypothesize the creation of a novel protein with superior antimicrobial qualities
and enhanced mineral homeostasis. This would represent promising new molecular
methodologies for the clinical exploitation in oral health maintenance.

3.2
3.2.1

Materials and Methods
Protein and peptides characterization

Synthetic statherin, histatin 1 and peptides derived from statherin or histatin 3
were purchased from Chinapeptide (Shanghai, China). All proteins and peptides used in
this study are listed in Table 1 (Table 1). Purity (> 95%) and Mr from each protein and
peptide were verified by high performance liquid chromatography (HPLC) and mass
spectrometry analysis. Protein/peptide solutions were prepared in 50 mM NaCl, pH 6.8,
at a protein concentration of 1 mg/mL for the following experiments.

3.2.2

Calculation of protein and peptide isoelectric points
Isoelectric points (pI) of statherin, histatin 1 and their peptides were determined

using the calculator developed by Gauci and coworkers. This approach calculates the pI
of a protein and peptide at a particular pH using user-specified pK values. The calculation
is repeated until the pH corresponding to a net charge of zero is found (Gauci, S et al.
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2008). pI values quoted were calculated using the Scansite option (Azzopardi, P et al.
2010).

3.2.3

Enamel demineralization assay
Enamel sample preparation was done as previously described (Siqueira, W et al.

2010). Briefly, human permanent first molars without defects were cleaned, rinsed, and
sectioned. After having the roots removed, the crowns were sliced sagittally into 4
sections (each with a 300 µm thickness) using a diamond saw, followed by grinding to a
thickness of 150 µm using sandpaper. Each specimen was coated with a layer of lightcured dental adhesive (3M ESPE ScotchbondTM Universal) and nail varnish, excluding an
untouched 2 mm window on the natural surface enamel.
Samples were randomly divided into 6 groups (N = 10 per group), as shown in
Table 1. Each specimen was submerged in 1mg/mL peptide/protein solution or distilled
water (control group) and incubated for 2 hours at 37oC. After this period, the samples
were then submerged in 1mL of demineralization solution (0.05M acetic acid; 2.2mM
CaCl2; 2.2mM NaH2PO4; pH 4.5) at 37oC for 12 days. Afterward, enamel slices were
removed from the solution and the remaining 1 mL of acidic solution was used to assess
the calcium and phosphate concentration released from enamel during the
demineralization process.

3.2.4

Calcium and phosphate analyses
The calcium concentration of the solution was assessed using a quantitative

colorimetric calcium determination assay (QuantiChromTM Calcium Assay Kit, Bioassay
Systems, Hayward, Calif., USA) with a UV-visible spectrophotometer determining the
optical density at a wavelength of 612nm. The phosphate concentration was also
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performed using a colorimetric assay (PiColorLock™ Gold Detection System, Innova
Biosciences, Cambridge, U.K.) and UV-visible spectrophotometer, determining the
optical density at a wavelength of 635 nm. All samples were analyzed in triplicate.

3.2.5

Candida albicans killing assay
Candida albicans (ATCC 90028) colonies were picked from a Sabouraud

Dextrose Agar (SDA) plate (<1 week old) and suspended in 5 mM potassium phosphate
buffer, pH 7.0, to a final OD 620 nm of approximately 0.3. From this suspension, 50 µl
was added to 50 µl of a serial dilution series of DR9, DR9-DR9, DR9-RR14, RR14 and
Histatin 3 in a 96-well polypropylene microtitre plate. The initial concentration during
the dilution series of each peptide or protein was 214 µM. After 1.5 h of incubation at
37◦C,	
  50	
  μl	
  from	
  selected	
  wells	
  were	
  diluted	
  in	
  9	
  ml	
  phosphate-‐buffered	
  saline, pH 7.0
and 25 µl aliquot of the diluted suspension was plated on SDA. After 48 h of incubation
at 30 ◦C,	
   cell	
   viability	
   was	
   assessed	
   by	
   colony	
   counting,	
   using comparisons with the
number of cells in a control sample incubated without the presence of peptide or protein.
This experiment was carried out three dependent times and each time in duplicate.

3.2.6

Statistical analyses
Statistical procedures were performed with the software package Minitab 13.1.

After checking for normal distribution, we subjected the data to analysis of variance
(ANOVA) followed by Tukey’s test. The level of significance was set at a value of p <
0.05.
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3.3

Results

Isoelectric points were calculated for each peptide and protein in pH 6.8. Histatin 1, a
positive protein, demonstrated a pI of 7.00 while statherin, a negative protein, showed a
pI of 4.41. DR9, the natural statherin peptide, showed a pI of 3.63 while DR9-DR9
reached the lowest pI value, 3.44 and RR14 showed the highest value, 11.00, whereas
DR9RR14 exhibited an intermediate PI value of 7.16. Values are demonstrated in Table
3-1.

Table 3-1: Constructed peptides derived from statherin and histatin and their
calculated pI. Note. pS is a phosphorylated serine.

1

DR9

DpSpSEEKFLR

3.63

2

DR9-DR9

DpSpSEEKFLRDpSpSEEKFLR

3.44

3

DR9-RR14

DpSpSEEKFLRRKFHEKHHSHRGYR

7.16

4

RR14

RKFHEKHHSHRGYR

11.00

5

Statherin

DpSpSEEKFLRRIGRFGYGYGPYQPVPEQPLYPQPYQPQYQQYTF

4.41

6

Histatin 1

DpSHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN

7.00

7

Distilled water

None
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To gain insight into the biological functions of those new constructed pellicle
peptides when adsorbed on the enamel surface, we decided to evaluate the effects of
those peptides on in vitro enamel demineralization. The amounts of phosphate released
from the enamel specimens after 12 days in demineralization solution are shown in Table
3-2. The control group (non-peptide coated) shows the highest phosphate loss. No
statistically significant differences were observed between the amount of phosphate
released from the groups treated with DR9-RR14 and histatin 1 or between statherin
group and its naturally occurring peptide, DR9. On the other hand, statherin and DR9
demonstrated a significantly lower phosphate loss when compared to DR9-RR14 and
histatin 1 groups, while DR9-DR9 showed the smallest phosphate loss compared with
any other group (p<0.05).
In relation to calcium released, the results were very similar to the phosphate
released. DR9-DR9 and statherin showed the lowest calcium loss, followed by DR9
group (Table 2, p<0.05). DR9-RR14 and histatin 1 groups demonstrated no statistically
significant differences, but both groups demonstrated a significant calcium loss when
compared to DR9-DR9, statherin and DR9 groups which held an intermediate value
among the groups. As expected, all peptide/protein groups demonstrated significant
difference when compared to the control group (Table 3-2).
Ca/PO4 ratio was calculated for each tested group, a percentage variation of less
than 9% was observed among the groups. DR9-DR9 group reached the smallest ratio of
1.44 while DR9-RR14 showed the highest ratio of 1.55.
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Table 3-2: Calcium and phosphate release from human enamel sections
Means and standard deviations of calcium and phosphate released from human enamel
sections first exposed to constructed pellicle peptides, proteins or water (control)
followed by exposure to the demineralizing solution (n = 10 per group). Different letter
superscripts indicate statistical difference, and same letter superscripts indicate no
statistical difference within the same column, according to Tukey’s test (p<0.05).

Peptide

Mean PO4 Conc. Mean Ca Conc. Ca/Po4
(mM/mm2)
(mM/mm2)
Ratio

Water

3.09 ± 0.52A

4.56 ± 0.49A

1.47

DR9-RR14

2.01 ± 0.71B

3.13 ± 0.46B

1.55

DR9

0.92 ± 0.28C

1.45 ± 0.13B

1.57

Statherin

0.79 ± 0.21C

1.17 ± 0.31B,C

1.48

Histatin 1

1.81 ± 0.22B

2.83 ± 0.17B,C

1.56

DR9-DR9

0. 44 ± 0.18D

0.63 ± 0.16D

1.44
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In order to evaluate the antimicrobial activity of these new constructed peptides,
Candida albicans killing assay was performed. IC50 was calculated for all tested peptides
(Figure 3-1). Histatin 3 and its functional domain (RR14) reached IC50 values of 5.4 and
49.0 µM respectively. Statherin constructed peptides DR9 did not reach IC50 value while
DR9-DR9 reached at 200 µM. Interestingly, DR9-RR14, reached IC50 at 117 µM,
demonstrating a significant antimicrobial activity.
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Figure 3-1: Candida albicans killing Assay of newly constructed peptides and
histatin3.
A) DR9, B) DR9-DR9, C) DR9-RR14, D) RR14 and E) histatin 3. The inset Table
indicates the IC50 values.
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3.4

Discussion

Our group has demonstrated that a single functional domain represented by a 14
amino acid residue (RR14) located within the middle portion of histatin 3 keeps higher
antifungal activity (Xu, T et al. 1991). Moreover, the multiplication of this functional
domain, that in theory anticipate the effects of evolutionary trends and improve
functional properties, demonstrated a significantly higher antifungal protection,
suggesting a synergistic effect upon active domain multiplication (Oppenheim, FG et al.
2012). In analogy, we hypothesized that recently identified and characterized AEP
phosphorylated statherin peptide, when duplicated may show increased biological
function property on the enamel surface. The significance of generating novel constructs
with increased adhesion to enamel is to increase the degree of substantivity that is related
to the rate of clearance of a biologically active molecule from its site of action. It is also
well known that salivary molecules that are more retentive to oral surfaces have a lower
rate of proteolytic degradation (Gibbons, RJ et al. 1988; McDonald, EE et al. 2011).
Apart from domain duplication, another potentially useful approach to generate
functionally improved pellicle constructs is the preparation of hybrid molecules. While
functional domain repeats are designed to augment a single functional characteristic, the
combination of two different functional entities can lead to constructs with multiple
functions. The hybrid approach is particularly promising for pellicle components, since
some AEP peptides show a high affinity for HA whereas other AEP peptides have
different functions such as antimicrobial properties (Siqueira, W et al. 2012;
Vukosavljevic, D et al. 2011). Examples of such synthetic bi-functional constructs in the
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protein field are cystatin-histatin (Bobek, LA et al. 1993) and statherin-osteopontin (Raj,
PA et al. 1990) chimeras.
Thus, this study has pioneered in functionally characterizing the AEP’s
constructed peptide based on in vivo natural proteins/peptides identified by proteomics
technology (Siqueira, W and Oppenheim, FG et al. 2009). DR9, a natural functional
domain of statherin, was duplicated and/or incorporated to RR14, a functional domain of
histatin 3. Our in vitro results showed that all constructed peptides have the potential to
provide some level of protection against acid injury. Interestingly, a significant functional
difference was observed when statherin or its single domain (DR9) was compared to its
sibling-duplicated domain (DR9-DR9). The duplication of statherin functional domain
resulted in a reduction of more than 50% of mineral loss, when compared with statherin
or DR9 groups.

We can speculate that this difference is based on the number of

phosphorylated sites, where DR9 or statherin are phosphorylated in the amino acid
residues 2 and 3; DR9-DR9 is phosphorylated in the amino acid residues 2, 3, 10 and 11.
As observed before, the presence or the number of phosphorylation sites can significantly
affect the adsorption to the hydroxyapatite and the process of enamel demineralization
protection or calcium phosphate crystal growth inhibition (Hunter, GK et al. 2009;
Hunter, GK et al. 2013; Siqueira, W et al. 2010). In addition to phosphorylated sites;
DR9-DR9 has the lowest pI when compared to statherin and DR9 in pH 6.8, the
physiological salivary pH. This biochemical characteristic can facilitate the adsorption on
the enamel surface of this peptide (Moreno, EC et al. 1982). It was evident that
multiplying the N-terminal functional domain of statherin (DR9-DR9) is evolutionarily
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advantageous in promoting dental homeostasis, and it is expected that further studies on
peptides of interest will continue to uncover novel peptides for clinical exploitation.
As expected, RR14 showed a significant antimicrobial property compared to DR9
or DR9-DR9. More importantly, our hybrid peptide, DR9-RR14, demonstrated to retain
antimicrobial activity, despite 50% less active than RR14. This result confirms that the
combination of functional domains of salivary proteins could be part of the evolutionary
pathway and artificially development of these peptides can provide a promising new
methodology for enhancing prevention/treatment of oral diseases. Based on the limitation
of this study, it should be mentioned that the protective/antimicrobial behavior of
individual peptides might be different compared to their activity in the presence of other
peptides or proteins, as the case of in vivo formed AEP. For instance, some studies have
revealed differences in the adsorption behavior of histatins in the presence of other
proteins (Yin, A et al. 2006). Some other research has shown that casein and mucin,
when mixed, were able to increase the erosion-inhibiting properties of the pellicle
(Cheaib, Z and Lussi, A et al. 2011). No studies have as yet been carried out to address
the functional effect of those newly constructed peptides in such multi-component protein
films with the incorporation of other constructed peptides or histatin 1 or statherin.
However, a single-component functional exploration represents the first step in gaining
insights into the possible role of these peptides in enamel protection as well as
antimicrobial/biofilm modulation. Knowledge obtained here may provide a basis for the
development of stable (proteinase-resistant) synthetic peptides for therapeutic use against
dental caries, dental erosion and/or oral candidiasis.
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4

The effect of pH on killing properties of chitosan
nanoparticles against Candida albicans
4.1

Introduction

Candida albicans plays an important role in the pathogenesis of oral candidiasis
and denture stomatitis. It comprises about 80% of all isolated microorganisms from these
types of oral lesions (Martinez, RF et al. 2013 and Pereira, CA et al. 2013). Although,
Candida albicans is abundantly present in the normal flora of the oral cavity, the
imbalance between host and fungus can lead to the initiation of oral candidiasis. This
imbalance can be resulted from several factors, including diminished salivary flow,
immune defects, smoking and poor oral hygiene (Pinelli, LAP et al. 2013). Oral Candida
infection can be treated by several commercial antifungal agents such as amphotericin B,
nystatin, miconazole, itraconazole, clotrimazole and ketoconazole. However, multiple
adverse side effects, including bitter taste, allergic reactions, host toxicity, interruption
with cellular function and drug interactions are associated with the application of these
drugs despite their efficacy (Amanlou, M et al. 2006; Bakhshi, M et al. 2012 and
Donnelly, RF et al. 2008). Furthermore, Candida albicans is capable of reducing drug
accumulation by the expression of efflux pump and therefore resisting to antifungal
agents (Sanglard, D et al. 2002). Hence, many studies have focused on the development
of natural products to treat oral candidiasis and overcome the weaknesses of these
commercial antifungal drugs.
Chitosan is a linear amino-polysaccharide with mucoadhesive properties, which
consists of two monosaccharides, GlcNAc (N-Acetyl glucosamine) and D-glucosamine
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(GlcN) combined with glycosidic linkages (Sundar, S et al. 2010). Chitosan is an
deacetylated form of chitin, which is mostly extracted from crab and shrimp offals. The
deacetylation is achieved by boiling chitin at 80-140 °C in concentrated alkali such as
sodium hydroxide or potassium hydroxide (30–60% w/v) for up to 10 hours (Kumar,
MNV et al. 2000 and Rabea, EI et al. 2003). This amino-polysaccharide possesses several
characteristics, including biodegradability, biocompatibility and low toxicity, which
make it an effective and suitable tool in many different medical applications, mainly
based on its antimicrobial and antifungal properties (Rinaudo, M et al. 2006 and Rabea,
EI et al. 2003). Several mechanisms have been proposed to explain how chitosan
functions as an antimicrobial agent. These proposed mechanisms include altering cell
permeability by interacting with the membrane of the bacterial cell, inhibition of the
production of toxin and inhibition of mRNA synthesis and various enzyme activities
crucial for bacterial survival (Sudarshan, NR et al. 1992; Cuero, RG et al 1991; Seo, HJ
et al. 1992 and Chen, CS et al. 1998). However, the exact mechanisms by which chitosan
serve its antimicrobial activity remains to be elucidated. In addition, Chitosan is dissolved
in water at acidic pHs since the amino groups can be protonated, enabling the positively
charged chitosan molecules interact with the negative charges of the cell surface.
However, since chitosan is insoluble in water at neutral and basic pHs that limits its
antimicrobial activity at neutral and basic pHs (Agnihotri, SA et al. 2004).
Due to mentioned pH-sensitive behavior, chitosan, in the form of nano- or
microparticles, can be used to encapsulate and deliver proteins and/or peptides as well as
different drugs. Different approaches have been taken to create chitosan nanoparticles
such as emulsion crosslinking, ionic gelation, emulsion-solvent extraction, emulsion-
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droplet coalescence and emulsification solvent diffusion. Chitosan nanoparticles used in
this study were constructed by the ionic gelation method and with the employment of
tripolyphosphate (TPP) as a cross-linker. In this report, we evaluate the antifungal
activity of chitosan particles. We also include different initial concentrations of chitosan
in the gelation process of constructing particles and its impact on the resulted particle’s
antifungal activity. Finally, the antifungal effect of chitosan nanoparticles is compared at
different pHs.

4.2
4.2.1

Material and methods
Chitosan nanoparticles’ construction

Chitosan nanoparticles were constructed using an ionic gelation method. In
summary, chitosan dissolved in 1.75% acetic acid and 0.5% Tween-80, is subject to
adding 0.84 mg/ml TPP solution, drop by drop in ratio of 1:4. The mix will be then
stirring continuously, overnight, at room temperature. In this process, TPP behaves as a
cross-linker in between the chitosan molecules. The result of this interaction will be
chitosan nanoparticles with small pores on the surface. For the purpose of this study,
chitosan nanoparticles were made with different initial concentration of chitosan in the
solution of constructing particles. 0.05%, 0.25%, 0.5% and 1% were the initial
concentrations of chitosan, used in this study to produce chitosan nanoparticles. The size
and surface charge of the chitosan nanoparticles were measured, ≈ 10 nm and +30 to +35
using Zeta sizer nano and Zeta potential analyzer (Brookhaven instruments crop.)
instruments respectively. Chitosan nanoparticles were harvested by centrifugation at
16000 g for 30 minutes and then were dried and stored for the following experiments.
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4.2.2

Candida albicans killing assay
The Candida albicans strain used in this study was ATCC90028. Yeast cells were

precultured on the Sabouraud Dextrose Agar (SDA) media plates for 48 hours, at 37o C.
The SDA powder medium (Catalog number 210950) was purchased from BD Company.
Less than one week old, Candida albicans colonies were picked from SDA plates and
suspended in 5 mM potassium phosphate buffer, pH 7.0, to a final OD of ≈ 0.3 at the
wavelength of 620 nm. In addition, a serial dilution of chitosan/chitosan nanoparticles
was made in a 96-well polypropylene microtitre plate, starting from 2 mg/ml. 50 ul of the
yeast suspension made in the previous step, was added to 50 ul of serial dilution series of
chitosan/chitosan nanoparticles in the microplate wells. After mixing the cells with the
chitosan solution, the plate was incubated for 1.5 hours at 37oC.

4.2.3

Evaluation of cell viability
After the incubation time, 50 ul of the solution, from selected concentrations, was

diluted in 9 ml of phosphate-buffered saline, pH 7.0 and 25 ul of the diluted suspension
was then plated on SDA plates, after 48 hours incubation at 30oC, number of colonies on
each plate was counted and compared to the number of colonies on the control plate that
was incubated without chitosan (nanoparticles).

4.2.4

Chitosan nanoparticles suspension
In order to make chitosan nanoparticle suspensions for the killing assay, dried

chitosan nanoparticles were measured by weight and added to the buffer required for the
experiment. 5 mM potassium phosphate buffer was used for pH 7.0 and acetate buffers
were used for pH 4.0, 5.0 and 6.0. In order to maximize the suspension of chitosan
nanoparticles into the buffers, 5 minute sonication was used.
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4.3
4.3.1

Results
Chitosan nanoparticles possess a more effective antifungal
activity compared to plain chitosan

The killing assay was performed for plain chitosan and chitosan nanoparticles in 5
mM potassium phosphate buffer pH 7.0, for Candida albicans. The percentage of cell
viability in different concentrations of chitosan and chitosan nanoparticles was calculated
compared to the control (Figure 4-1). As shown in Figure 4-1, chitosan nanoparticles was
able to kill 100% of the cells in a concentration 4 times less (500 ug/ml) than the
concentration (2000 ug/ml) that is required for chitosan (non-nanoparticle) to kill 100%
of the cells. Furthermore, IC50, the concentration in which an antimicrobial agent can kill
50% of the cells, was calculated for non-nanoparticle chitosan and chitosan nanoparticles.
Table 4-1 shows the IC50 values, where again chitosan nanoparticles exhibit a killing
efficiency four times more effective when compared to non-nanoparticle chitosan.
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Figure 4-1: Killing effect of chitosan nanoparticles and non-nanoparticle chitosan
against Candida albicans.
Candida albicans cells were incubated with different concentrations of chitosan/chitosan
nanoparticles for 1.5 hours and the viability of the cells were compared to the controls by
plating them on the SDA plates and comparing the number of colonies after 48 hours.
Graph A and B represents the results for non-nanoparticle chitosan and chitosan
nanoparticles respectively. Both experiments were done in duplicate and the graphs show
the average.
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4.3.2

The Killing effect of chitosan nanoparticles made with
different initial concentrations of chitosan proved to be
significantly different
Chitosan nanoparticles were constructed with ionic gelation method initiating

with different chitosan concentrations in the solution. The Killing effect of constructed
nanoparticles was examined against Candida albicans in 5 mM potassium phosphate
buffer pH 7.0. The percentage of cell viability compared to the controls was plotted
against concentration for each group of nanoparticles (Figure 4-2). This experiment was
performed to investigate whether the initial concentration of chitosan used in construction
of nanoparticles can affect the antifungal activity of resulted nanoparticles against
Candida albicans. As shown in Figure 4-2, chitosan nanoparticles showed a more
effective antifungal activity when a higher initial concentration of chitosan was used to
construct nanoparticles. This can be explained by the fact that chitosan nanoparticles
made with 1 or 0.5% of initial chitosan concentration required 4 times less concentrations
to kill 100% of the cells compared to the nanoparticles initiated in 0.25 and 0.05%
chitosan.
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Figure 4-2: Killing effect of chitosan nanoparticles made with different initial
chitosan concentrations.
Candida albicans cells were incubated with different concentrations of non-nanoparticles
chitosan/chitosan nanoparticles for 1.5 hours and the viability of the cells were compared
to the controls by plating them on the SDA plates and comparing the number of colonies
after 48 hours. A) 1% chitosan, B) 0.5% chitosan, C) 0.25% chitosan and D) 0.05%
chitosan; each experiment was performed in duplicate for three times. Error bars are
based on the standard deviations of replicates.
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4.3.3

Chitosan nanoparticles show a most efficient killing effect in
pH 4
Since chitosan nanoparticles constructed with the initial concentration of 0.5%

and 1% showed the highest killing effects among other constructed nanoparticles and to
control the viscosity of chitosan solution, we chose 0.5% chitosan solution for future
nanoparticle construction. We further investigated the antifungal activity of these
nanoparticles in different pHs. To do this, the killing assay was performed in acetate
buffer pH4.0, 5.0, 6.0 and 5 mM potassium phosphate buffer pH 7.0. Then, the
percentage of cell viability compared to the control was plotted against the concentration
of chitosan nanoparticles (Figure 4-3).
As shown in Figure 4-3, chitosan nanoparticles represent a higher antifungal
activity in acidic pHs since chitosan nanoparticles require to be two and four times more
concentrated in pH 5.0 and 6.0 compared to pH 4 respectively in order to kill 100% of
cells. Furthermore, the comparison of the IC50 of chitosan nanoparticles in different pHs
confirms that chitosan nanoparticles show the most effective antifungal activity at pH 4,
with the IC50 of 39 ug/ml.
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Figure 4-3: Killing effect of chitosan nanoparticles in different pHs.
All the killing assays were performed the same as previous ones, except for the buffers, in
which Candida albicans cells were exposed to the chitosan nanoparticles. A) pH=4, B) pH=5,
C) pH=6 and D) pH=7. (For all the acidic pHs, acetate buffer with different pHs were used).
Each experiment was performed in duplicate for three times. Error bars are based on the
standard deviations of replicates.

62

Table 4-1: IC50 of different groups against Candida albicans.

Group

IC50 (ug/ml)

Plain chitosan

875

Chitosan nanoparticles (1% initial chitosan)

200

Chitosan nanoparticles (0.5% initial chitosan)

234

Chitosan nanoparticles (0.25% initial chitosan)

438

Chitosan nanoparticles (0.05% initial chitosan)

167

Chitosan nanoparticles (in pH 7)

244

Chitosan nanoparticles (in pH 6)

750

Chitosan nanoparticles (in pH 5)

109

Chitosan nanoparticles (in pH 4)

39
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4.4

Discussion

Oral candidiasis is an oral condition that is getting more difficult to treat due to
the Candida albicans’ resistance to the available antimicrobial agents. Studies to develop
a new treatment system for this disease are challenging and ongoing. Our findings
propose a novel antimicrobial agent for oral candidiasis. These chitosan nanoparticles are
novel for this purpose, in the sense that they can be used as a carrier for other drugs and
have an efficient synergic effect along with the main drug. The ability of these
nanoparticles to serve their most effective antifungal function in both pHs 4 and 7, makes
them even more promising, since these two pHs are the most common pHs in the oral
cavity. The normal pH of saliva is around 6.8 but following ingesting fermentable
carbohydrates the pH of the oral cavity will drop quickly due to the bacteria acid
production. Besides, this pH drop is more extreme in individuals with poor oral health.
However, the buffering nature of saliva will return the pH to the normal pH quite fast
(Stephen, RM et al. 1940 and 1944). Furthermore, chitosan nanoparticles showed a better
effect in acidic pH, which is a crucial pH in the oral environment, since the acid will
predispose the demineralization of tooth enamel. Moreover, nano-scale size of these
particles enables them to penetrate into the biofilm and diminish the organisms both from
inside as well as outside of the biofilm. The Polysaccharide nature of chitosan will also
assist in particle penetration into the biofilm.
Nano/micro particles have recently drawn significant attention as drug delivery
carriers, since they can be targeted directly to the intended tissue, which will reduce the
side effects and increase the lifetime of the drug. With nano/micro particles’ application,
drug release could be activated by chemical or physical factors such as temperature, pH,
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ionic strength, biological factors’ concentration, and etc. Thus, stimuli dependent
particles are promising drug carriers, since they can only respond to a condition which
confirms the pathogenic state in which the specific drug should be released.
Chitosan particles exhibit a pH-sensitive property because of the large number of
amino groups in the chitosan chain. The optimum pH for a drug encapsulated inside
chitosan particles to be released is pH 4-5 (Aydin RST et al. 2012). This feature of
chitosan particles is extremely important for oral application, since most of the oral
complications such as dental caries and dental erosion initiate in acidic conditions in the
oral cavity. This study took the first steps of developing a new therapeutic/preventive
drug application in the oral cavity. Penetration of these nanoparticles into the biofilm and
controlled release of the encapsulated drug when necessary is an outstanding
phenomenon, which if happens can revolutionize the future of dental care and treatment.
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5

Conclusion and discussion

5.1 General rationale and conclusion
Inefficiency in oral health could be a major threat to an individual’s overall
health, since insufficient oral care can contribute to the severe health complications, such
as stroke, diabetes development, cardiovascular disease, atherosclerosis, adverse
pregnancy and many more extreme consequences (Scannapieco, FA et al. 2003).
Because of the increase in prevalence of oral problems and resistance of different
bacteria/fungi present in the oral cavity to the current treatments, novel methods of
treatment or preventive mechanisms are demanding (Truin, GJ et al. 2005 and Tsai, H. et
al. 1997). For example, oral antifungal drugs such as azoles are applied for the treatment
of Candida albicans infections; however, this method of treatment is becoming very
limited due to the ongoing organism resistance to these agents. This case has reached the
point that nowadays only a limited number of available antifungal agents such as
fluconazole, itraconazole, amphotericin B and a few more, could be registered for this
purpose (Carrillo-Munoz, AJ et al. 2006). In addition to organism resistance, continuous
use of chemical products will create unpreventable and unwanted side effects that could
become more hazardous in special cases. In the case of oral infections, such as
Candidiasis, an idealistic antifungal/antimicrobial agent would be the one with a broadspectrum efficacy and no toxicity to the host (Ito, CY et al. 2004). The idea of using
natural materials to treat patients has always been a more promising and safe method to
address most of the problems that we are facing with currently available chemical
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products (Cruz, MC et al. 2007; Rojas, JJ et al. 2006 and Holetz, FB et al. 2002).
More than 2000 different proteins were detected in human saliva, each serving
different functions and properties. Among all the salivary proteins, 130 of them appeared
to be part of AEP (Siqueira, W et al. 2007). AEP is an organic layer; formed on the
tooth's surface that has precursors from different origins, such as saliva, bacterial
products, oral mucosa and gingival crevicular fluid (Siqueira, W et al. 2007 and Siqueira,
W et al. 2012). AEP serves a strategic role in the oral cavity by neutralizing the acid
products of bacterial metabolism, governing the types of early colonizers on the tooth
surface and monitoring the demineralization and remineralization of the enamel (Hara
and Zero, et al. 2010; Siqueira, W et al. 2010; Siqueira, W et al. 2012; Zahradnik and
Moreno, et al. 1977; Chaudhuri, B et al. 2007; Gibbons and Hay, et al. 1989; Li, J et al.
2004). Therefore, AEP and its composition are a crucial element in preserving the oral
health and it is hypothesized that altering its composition could shift the physical and
chemical reactions, which will eventually lead to an irreversible dental condition, such as
tooth decay.
There are salivary proteins that provide natural antimicrobial/antifungal properties
against certain microorganisms in the oral cavity to keep the biological balance between
the beneficial and virulence organisms in the oral environment (Tenovuo, J et al. 1989).
Most of which, are evolutionary occurred proteins present in different animal species as
part of the innate immune system (Hoffmann, JA et al. 1999). These natural antimicrobial
proteins usually have wide activity spectra against different bacteria, fungi or viruses.
Antimicrobial/antifungal salivary proteins have a small cationic region in common,
within their structure, which could provide the killing effect of the protein on target
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organisms.
Histatins are a family of salivary proteins with antimicrobial activity. These
proteins are all products of 2 gene loci; therefore, all of them possess a common cationic
region, which seems to be the functional domain of the protein (Azen, EA et al. 1973 and
Sabatini, LM et al. 1989). Histatins vanish immediately after secretion into the oral cavity
because of degradation; despite the resulted fragments appear to sustain the activity,
while carrying the functional portion of the original protein (Castagnola, M et al. 2004;
Groot, F et al. 2006).
Some other saliva components inhibit the calcium and phosphate precipitation in
the oral cavity, which is a very essential feature of saliva to keep the oral fluid
supersaturated from these minerals that will aid the remineralization of the teeth enamel,
when it is required (Gron, P et al. 1976). These members of saliva are usually the proteins
that are selectively adsorbed onto the enamel surface and therefore, seem to be AEP
precursors (Hay, DI et al. 1973). Examples of such proteins are proline-rich proteins and
a small tyrosine-rich acidic protein called Statherin (Oppenheim, FG et al. 1971; Hay, DI
et al. 1974; Hay, DI et al. 1973).
Recently, several studies revealed high susceptibility of functional salivary
proteins, including histatins and statherin, to the oral proteases and/or bacterial enzymes
presented in the oral cavity. Although some of the fractions could remain functional after
the cleavage to some point, this immediate degradation causes remarkable decrease in the
overall function (Helmerhorst, EJ et al. 2006; Siqueira, W et al. 2010; 2007b; Siqueira,
W et al. 2009; McDonald, EE et al. 2011; Castagnola, M et al. 2004; Groot, F et al.

70

2006). Meaning that, if feasible to keep those proteins active in the same scale as they are
produced by salivary glands, this could be employed as a natural promising therapeutic
method in the dentistry field. To evaluate this hypothesis, this study has pioneered a
method of encapsulation for synthetic salivary peptides/proteins to be beneficial for the
oral application.
Recently, our group, taking advantage of novel proteomics techniques, has
detected a small peptide consisting of only 9 amino acids termed as DR9, in the AEP
composition (Siqueira and Oppenheim, et al. 2009). This peptide appeared to be the Nterminal part of statherin, which is believed to be its functional domain (Long, JR et al.
1998; Raj, PA et al. 1992). DR9 peptide naturally occurred in the oral cavity and
exhibited the same affinity to the HA and functionality as the original protein, statherin
(Xiao, Y et al. 2010). Inspired by this naturally existed peptide in AEP composition, the
idea of analyzing other salivary proteins’ functional domain and accelerating the
evolution pathway by combining them together or duplicating them, came to our mind.
Eventually, from the data collected in this study, we confirmed that only the
functional domain could carry the biological function of tested salivary proteins of
interest. Also, evolutionary new generation proteins could be constructed artificially by
combining different protein functional domains and/or duplicating protein functional
domains. This idea was inspired by the fact that ordinarily, proteins over the track of
evolution misplace the portions of their sequences that are not essential for their function
and replicate the functional portions instead, therefore saving energy and improving their
functional capacity (Oppenheim FG et al. 2012; Troxler, RF et al. 1997). Hence, this
could be the evolutionary pathway that these salivary proteins might take after millions of
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years, which could be induced artificially by synthetic methods and in this way, we could
benefit from the result of evolution millions of years ahead of the time that it would
naturally occur.
A method of oral application for proteins was also investigated in this study,
which proved to be likely, even though we took only the first steps and there are lots of
limitations yet to be addressed.
Recently, chitosan, a cationic polysaccharide, has attracted vast attention from the
pharmaceutical fields due to its preferential biological properties to deliver different
active drugs or proteins to the side of action (Kumar, MNV et al. 2000; Rabea, EI et al.
2003). Chitosan micro/nanoparticles have drawn significant attention recently, since not
only they have all the critical features of a drug delivery agent, including nontoxicity,
biodegradability and being physically inducible, but also, they have bonus antimicrobial,
antifungal and wound healing properties, which could be highly beneficial for the dental
application (Rinaudo, M et al. 2006; Rabea, EI et al. 2003). Moreover, chitosan
nanoparticles have a pH sensitive behavior, in terms of the size of pores on their surface,
which makes them more favorable for the oral application. Since they could only release
the proteins/peptides when the pH drops to the acidic point, which is accounted as a red
flag in the oral cavity since at the acidic point heavy demineralization assault on the teeth
tissue initiates.
Another approving property of chitosan nanoparticles for this application is the
extremely small size of the nanoparticles, because of which, it is hypothesized that they
could penetrate into the micro-scale pores in between the biofilm components. This
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penetration will make the nanoparticles part of the biofilm and the protein/peptide release
from nanoparticles will diminish the biofilm from the inside when the pH drops to the
acidic point, which is the point that the damage to the teeth tissue upraises. Particles’
penetration into the biofilm is highly critical in dentistry because they will be able to
reach to the part of the biofilm, which is inaccessible by brushing and other manual types
of cleaning. These dental biofilms are also highly resistant to antimicrobial products
compared to the individual microorganisms, which is because of the exopolysaccharide
matrix produced by microorganisms (Costerton, JW et al. 1995). This compact structure
of the biofilms makes them resistant to the host immune system as well, causing them to
be very challenging to control and eliminate (Lewis, K. et al. 2001).

5.2
•

Final Conclusion

Only the functional domain of statherin and histatin, termed as DR9 and RR14
respectively, showed some level of the original protein’s activity.

•

Combination/duplication

of

salivary

protein

functional

domains

could

increase/combine their activity.
•

Chitosan nanoparticles constructed by the ionic geletion method, exhibited a
higher antifungal activity compared to the non-nanoparticle chitosan and also they
presented the most efficient activity when higher concentrations of chitosan was
used to construct the nanoparticles.

•

Chitosan nanoparticles exhibited the highest antimicrobial activity in pH 4, which
is the critical pH in the oral cavity, at which several dental complications initiate,
followed by neutral pH which is the normal pH of the oral cavity.
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5.3

Challenges and limitations

Similar to any other project, presented one has several limitations to be addressed.
One of the major concerns about this project is that since more than 1000 different
microorganisms coexist in the human oral cavity (Paster, BJ et al. 2006 and Zaura, E et
al. 2009), and chitosan nanoparticles might have different effects, in terms of toxicity,
towards them, this could interrupt the natural balance in between the oral microbiota.
Moreover, the polysaccharide nature of chitosan might make it consumable for some
bacteria, which could massively increase their quantity and proportion in the biofilm,
whether the bacteria is an acute virulence or a beneficial normal flora. One approach for
this challenge could be investigating the effect of chitosan nanoparticles on all the critical
microorganisms presented in the oral microbiota as well as performing multispecies
assays to evaluate the effect of chitosan nanoparticles on the multispecies communities,
which is mimic to the biofilm condition. This way, there will be the possibility to
investigate how different microorganisms will react when exposed to chitosan both
individually and in a biofilm format and therefore, if there could be any other approach to
make the method more feasible.

5.4

Future directions

This could be a novel method in dentistry if a therapy for different oral
pathologies could be designed using natural salivary proteins or peptides. Although
acquiring a detailed understanding of protein/peptide encapsulation and release into/from
chitosan nanoparticles, in different physical conditions, such as different pHs, will be
essential to move the project forward. Saliva pH can vary from 3 to 6.8 in different
conditions; therefore protein/peptide release from the chitosan nanoparticles should be
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examined in buffers with this pH range as well as in saliva itself. In addition, the effect of
these particles loaded with the proteins should be investigated in single or multispecies
biofilms in different conditions. This will give us an understanding of how the whole
biofilm will react to chitosan nanoparticles rather than only a single microorganism.
Finally, it has to be tested in vivo in a rat model before being able to move it to the
clinical trial.
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